Author Archive: BIOtechNOW Editor

Sciad Newswire and BIO form media partnership for the World Congress on Industrial Biotechnology

BIO World Congress

The Sciad newswire team are delighted to be partnering with BIO to help with the 2015 World Congress on Industrial Biotechnology in Montréal. From the 19th to the 22nd of July, experts and investors in industrial biotechnology will be at the Palais des Congrès de Montréal for the world’s foremost industrial technology conference. Sciad will be helping BIO to drive their media visibility, to help make sure the event is as successful as can be. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

FDA Acts on Biosimilars


The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration with regard to implementing the particulars of how the biosimilar approval pathway would be implemented.  The U.S. Food and Drug Administration has issued a series of draft Guidances indicating how it was considering implementing the biosimilar approval pathway contained in the Act.  The Guidances were expressly “draft” in nature, and were the subject of public hearings with the Agency welcoming Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

BIO Congratulates BioGENEius Winners!

2015 BioGENEius Challenge Winners

The 2015 International BIO Convention brought together some of the top biotechnology experts from around the world - some of whom are still in high school! BIO would like to congratulate, Anvita Gupta and Austin Wang, the winners of the annual International BioGENEius Challenge – the premier competition for high school students that recognizes outstanding innovation in biotechnology! Anvita (12th Grade, Scottsdale, Arizona) won the Global Healthcare category for her project titled, Novel Therapeutics for Genetic Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?


In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,